Dr. Taylor Brianne Warmoth , MD
Internal Medicine - Rheumatology • Lubbock, TX
5220 80th St
Lubbock, TX 794242862
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Taylor Warmoth is listed in NPPES under Internal Medicine - Rheumatology.
-
NPI assigned on May 2, 2016; this date does not establish years in practice.
-
Published CMS data list 14,163 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J0897 — Injection, denosumab, 1 mg: 5,100 service units.
- J1745 — Injection, infliximab, excludes biosimilar, 10 mg: 4,422 service units.
- 36415 — Insertion of needle into vein for collection of blood sample: 591 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 32 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 4,266 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Gabapentin — 387 prescription fills, including refills.
- Methotrexate (Methotrexate Sodium) — 378 prescription fills, including refills.
- Tramadol Hcl — 313 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 43 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 65% of clinicians listed under Internal Medicine - Rheumatology in Texas (2024, 383 clinicians with data). Median for this group: 1,854. Middle half: 315 to 43,723.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,427 in 2021 to 14,163 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2021–2024.
Practice Location & Contact Primary Location
5220 80th St
Lubbock, TX 794242862
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Lubbock, TX. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Arthritis And Osteoporosis Associates, Llp. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Texas Tech University Health Science Center School Of Medicine
2016
What Public CMS Data Show
Internal Medicine - Rheumatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
335 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $418,609 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $325,581 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
6,042 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,276,621 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,876.94 across 31 records.
By nature of payment
- Consulting Fee: $2,538.00 across 1 record.
- Food and Beverage: $338.94 across 30 records.
Reporting-company totals
- AstraZeneca Pharmaceuticals LP: $2,538.00 across 1 record.
- Amgen Inc.: $305.06 across 28 records.
- ABBVIE INC.: $33.88 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
10 years (graduated 2016)
CMS Doctors and Clinicians data list 2016 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2016
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Warmoth has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Warmoth as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Lubbock and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 65% of clinicians listed under Internal Medicine - Rheumatology in Texas (2024, 383 clinicians with data). Median for this group: 1,854. Middle half: 315 to 43,723.
Too few clinicians listed under Internal Medicine - Rheumatology in Lubbock have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 70% of clinicians listed under Internal Medicine - Rheumatology in Texas (2024, 383 clinicians with data). Median for this group: $95,648. Middle half: $28,134 to $583,235.
Too few clinicians listed under Internal Medicine - Rheumatology in Lubbock have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 70% of clinicians listed under Internal Medicine - Rheumatology in Texas (2024, 383 clinicians with data). Median for this group: $68,490. Middle half: $20,366 to $457,991.
Too few clinicians listed under Internal Medicine - Rheumatology in Lubbock have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Internal Medicine - Rheumatology in Texas (2024, 441 clinicians with data). Median for this group: 1,332. Middle half: 437 to 2,733.
Too few clinicians listed under Internal Medicine - Rheumatology in Lubbock have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Internal Medicine - Rheumatology in Texas (2024, 441 clinicians with data). Median for this group: $955,505. Middle half: $281,058 to $2,071,873.
Too few clinicians listed under Internal Medicine - Rheumatology in Lubbock have Medicare Part D data for 2024 to compare.
7 active clinicians are listed under Internal Medicine - Rheumatology with a practice address in Lubbock, TX (546 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 893% from 1,427 in 2021 to 14,163 in 2024.
- 2021: 1,427
- 2022: 5,960
- 2023: 12,893
- 2024: 14,163
-
Medicare-allowed amount
Medicare-allowed amount increased 867% from $43,299 in 2021 to $418,609 in 2024.
- 2021: $43,299
- 2022: $190,161
- 2023: $386,037
- 2024: $418,609
-
Paid by Medicare
Paid by Medicare increased 821% from $35,361 in 2021 to $325,581 in 2024.
- 2021: $35,361
- 2022: $147,053
- 2023: $301,263
- 2024: $325,581
-
Medicare Part D prescriptions
Medicare Part D prescriptions went from 13 in 2020 to 4,266 in 2024.
- 2020: 13
- 2021: 275
- 2022: 991
- 2023: 3,565
- 2024: 4,266
-
30-day fills
30-day fills went from 13 in 2020 to 6,042 in 2024.
- 2020: 13
- 2021: 372
- 2022: 1,369
- 2023: 5,047
- 2024: 6,042
-
Part D drug cost
Part D drug cost increased 2884% from $76,293 in 2020 to $2,276,621 in 2024.
- 2020: $76,293
- 2021: $99,750
- 2022: $511,725
- 2023: $1,869,447
- 2024: $2,276,621
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $460.22 in 2021 to $2,876.94 in 2025.
- 2021: $460.22
- 2022: $755.62
- 2023: $556.68
- 2024: $736.87
- 2025: $2,876.94
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 31 records totaling $2,876.94.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,538.00 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $22.92 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $21.38 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $18.83 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $18.47 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $18.18 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.64 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $16.24 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $14.30 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $14.30 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
ENBREL | General | $14.03 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $13.87 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $13.52 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $12.96 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $11.78 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $9.18 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $8.95 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $8.92 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $8.48 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $7.88 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $7.70 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $7.64 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $6.93 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $6.37 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $6.25 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2020–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2021–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0897
Injection, denosumab, 1 mg
|
5,100 | 54 | $35.00 | $25.57 |
|
J1745
Injection, infliximab, excludes biosimilar, 10 mg
|
4,422 | 13 | $200.00 | $31.43 |
|
36415
Insertion of needle into vein for collection of blood sample
|
591 | 278 | $7.00 | $6.86 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
498 | 213 | $25.00 | $7.36 |
|
80053
Blood test, comprehensive group of blood chemicals
|
491 | 216 | $35.00 | $10.03 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
488 | 42 | $5.00 | $0.97 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
452 | 188 | $207.00 | $120.20 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
319 | 188 | $25.00 | $15.35 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
306 | 192 | $140.00 | $84.64 |
|
96415
Administration of chemotherapy into vein, each additional hour
|
200 | 19 | $70.00 | $25.95 |
|
96372
Injection of drug or substance under skin or into muscle
|
197 | 69 | $50.00 | $13.50 |
|
82306
Vitamin d-3 level
|
141 | 114 | $80.00 | $29.01 |
|
86160
Measurement of complement (immune system proteins), antigen,
|
134 | 35 | $35.00 | $11.53 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
101 | 21 | $300.00 | $120.21 |
|
81003
Automated urinalysis test
|
89 | 48 | $10.00 | $2.13 |
|
82565
Blood creatinine level
|
84 | 74 | $15.00 | $4.99 |
|
96365
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
|
75 | 18 | $125.00 | $58.38 |
|
82310
Calcium level, total
|
72 | 63 | $15.00 | $5.06 |
|
77080
Dxa bone density measurement of hip, pelvis, spine
|
61 | 61 | $200.00 | $36.28 |
|
J3489
Injection, zoledronic acid, 1 mg
|
60 | 12 | $220.00 | $6.39 |
|
20610
Aspiration and/or injection of fluid from large joint
|
58 | 28 | $206.00 | $86.52 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
48 | 48 | $318.00 | $157.65 |
|
73130
X-ray of hand, minimum of 3 views
|
26 | 15 | $60.00 | $34.93 |
|
85651
Red blood cell sedimentation rate, to detect inflammation, non-automated
|
26 | 16 | $15.00 | $4.02 |
|
86225
Measurement of dna antibody, native or double stranded
|
26 | 16 | $40.00 | $13.24 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Gabapentin | Gabapentin | 387 | 15,952 | $4,043.74 | 70 |
| Methotrexate | Methotrexate Sodium | 378 | 17,543 | $7,377.29 | 66 |
| Tramadol Hcl | Tramadol Hcl | 313 | 8,869 | $1,856.50 | 56 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 302 | 14,132 | $6,978.76 | 62 |
| Omeprazole | Omeprazole | 258 | 13,146 | $1,598.78 | 58 |
| Alendronate Sodium | Alendronate Sodium | 202 | 9,347 | $1,305.00 | 38 |
| Pregabalin | Pregabalin | 199 | 5,817 | $1,890.70 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 195 | 9,933 | $3,801.80 | 50 |
| Prednisone | Prednisone | 191 | 7,043 | $890.53 | 45 |
| Leflunomide | Leflunomide | 187 | 8,789 | $6,641.66 | 36 |
| Diclofenac Sodium | Diclofenac Sodium | 148 | 5,797 | $6,413.13 | 28 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 123 | 4,195 | $519.23 | 35 |
| Nabumetone | Nabumetone | 121 | 5,056 | $1,843.30 | 22 |
| Celecoxib | Celecoxib | 112 | 4,664 | $4,971.96 | 22 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 96 | 2,288 | $1,074.17 | 20 |
| Meloxicam | Meloxicam | 94 | 5,100 | $268.31 | 22 |
| Sulfasalazine | Sulfasalazine | 86 | 3,480 | $1,305.38 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 83 | 3,367 | $784.99 | 24 |
| Enbrel Sureclick | Etanercept | 82 | 2,470 | $654,604.37 | — |
| Amitriptyline Hcl | Amitriptyline Hcl | 73 | 3,810 | $1,010.80 | 20 |
| Colchicine | Colchicine | 73 | 2,690 | $3,662.55 | 20 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 70 | 2,685 | $2,893.82 | 12 |
| Humira(Cf) Pen | Adalimumab | 66 | 1,848 | $455,382.51 | — |
| Folic Acid | Folic Acid | 61 | 4,427 | $562.50 | 15 |
| Etodolac | Etodolac | 43 | 1,868 | $1,815.78 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-03-21NUCC Taxonomy Code: 207RR0500X
An internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and "collagen" diseases.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - RHEUMATOLOGY
I20210616002508
TX
7810280898
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Arthritis And Osteoporosis Associates, Llp
5220 80th St, Lubbock, TX 794242862
Phone: 8067712400
Secondary Practice Locations
3601 4th St
Lubbock, TX 794300002
Phone: 8067433150
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Rheumatology
Doctor of Medicine (M.D.)
Internal Medicine - Rheumatology
Doctor of Medicine (M.D.), Master of Business Administration
Internal Medicine - Rheumatology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 5220 80TH ST, LUBBOCK, TX 794242862 (Tel: 8067712400)
NPI status registered as active in NPPES database
Registered at 3601 4TH ST, LUBBOCK, TX 794300002 (Tel: 8067433150)
Registered at 3601 4TH ST, LUBBOCK, TX 794300002 (Tel: 8067433150)
Recorded as TAYLOR WARMOTH, M.D.
Internal Medicine (license number reported to NPPES: TX BP10056149)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Rheumatology Specialists in Lubbock
- Dr. Jose Del Giudice, MD
- Dr. Naga Bushan, MD
- Dr. John Pixley, MD
- Dr. Jitendra Vasandani, MD
- Dr. Theerapol Prasertsuntarasai, MD
- Dr. James Calmes, MD, MBA
Mailing Address
3601 4th St
Lubbock, TX 794300002
Phone: 8067433150